70% of all people will have at least 1 episode of OM, OM accounts for ~ 30% of all "sick" visits to pediatricians
Clinical Manifestations
Acute otitis media with effusion
"Presence of fluid in the middle ear accompanied by a sign of acute illness", Otalgia, otorrhea, hearing loss, Ear pulling, Systemic symptoms (Fever, irritability, lethargy, vomiting, diarrhea) Infants: irritability, vomiting and diarrhea
Otitis media with effusion
"Presence of fluid in the middle ear without signs or symptoms of acute infection"
Age: peak 6 to 18 months, in kids the estuation tube is more parallel (more prone to reflux)
Risk factors: Acquired- Day care, Smoking in home, 1st episode less than 1 year, "Early and often", 1st episode Streptococcus pneumoniae, predominance fall and winter. Congential - craniofacial abnormality
Diagnosis
history: presence or absence of systemic symptoms and ear pain
PE: Pneumatic otoscopy of tympanic membrane, Position (neutral, bulging, retracted), Color (pearly gray, red, pale, Degree of translucency (shiny, dull), Mobility, Tympanometry (air pump varies canal pressure), TM compliance, Middle ear pressure, Tympanocentesis, air-fluid level.
Treatment
Antibiotics (usually oral), Increased resistance in pneumococci
Myringotomy- surgery to put in tubes
Complications
Chronic otitis with effusion, Deafness, Speech and developmental problems, Mastoiditis, Meningitis, brain abscess, Lateral sinus thrombosis, Otitic hydrocephalus (treat otitis and hydrocephalus goes away), Cholesteatoma (soft tissue formation in inner ear) Labyrinthitis
Prevention
Breast-feeding (> 3 months), Not propping bottles, Prophylactic antibiotics
Tympanostomy tubes
Þ
Otitis media may be the result of bacterial superinfection of viral infection - therefore, preventing viral respiratory infections by immunization against RSV, influenza, parainfluenza, etc, may prove to have a greater impact on OM than immunization against Streptococcus pneumonia, nontypable Haemophilus influenzae, and Moraxella catarrhalis
Measles (Rubeola, "Hard Measles")
Etiologic Agent
: RNA virus, Paramyxovirus family, genus Morbillivirus Highly infectious (need a Ý % of population vaccinated)
Clinical Manifestations
"Measley-looking", Fever, Rash, Head first, nonspecific maculopapular, older rash is brownish
Four "K's"
Cough (always present)
Conjunctivitis (pink eye)
Coryza (runny nose)
Koplik spots
Complications
SUPER INFECTION
Þ Otitis media, Pneumonia, Croup, Diarrhea
Severe Complications
Encephalomyelitis: ~ 1/ 1000 cases
"Black measles" - severe hemorrhagic
Subacute sclerosing panencephalitis (SSPE) post infectious, ~1/100,000 cases, slowly progressing, behavioral and intellectual deterioration, Fatal within 6 months, Mortality ~ 3/1000 cases
Transmission
: Contact with infectious droplets, Airborne
Diagnosis
: by clinical presentation (4 "K's")
Treatment
: Vitamin A – kids getting Vit A do better
Prevention
: Vaccine (need >85 % of population vaccinated) Adverse effects of vaccine – fever several days later, febrile convulsions. Immune globulin – given to immunocompromised patients
: Asymptomatic (30-40%), Fever, headache, anorexia, malaise, Swollen salivary glands (60-70%), swollen Parotid gland (cannot see angle of jaw)
Complications
: Paroditis, Meningeal signs (10-30%) Encephalitis (~1/ 6000), Fatality 1.4%, Orchitis (Common after puberty; can lead to Sterility), rarely other glands (pancreatitis, oophoritis, thyroiditis), Hearing impairmen, or Mortality.
Transmission
: Direct contact via respiratory route
Diagnosis
: Clinical presentation: Parotid swelling. Consider other etiologies. Can use culture or serology to confirm
: Pneumonia, Hepatitis, Encephalitis, Herpes Zoster ("Shingles"), Reactivation of latent VZV, Dermatomal distribution, Fetal infection, Chronic skin disease, Disseminated Varicella or Zoster seen in Immunocompromised hosts (esp pregnant women) and is often fatal.
Transmission
: Direct contact, Airborne, Transplacental
Diagnosis
: Clinical (definitive), Culture, Rapid diagnosis (DFA or PCR), Serology (very useful to determine susceptibility)
Treatment
: Acyclovir- Oral for normal hosts, Parenteral - Compromised hosts